Monday, April 23, 2018
IBB 104.79 0.17 (0.16%)XBI 88.06 0.87 (0.98%)
Ticker Current Price Change Graph
IBB 104.79 0.17 (0.16%)
XBI 88.06 0.87 (0.98%)
Last updated: ago
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Endpoints Careers
  • About
  • Advertise
  • Privacy Policy
  • Reader center

The under-40s: How does the next generation of biopharma executives view the future?

by Endpoints Staffenvelope — on April 23, 2018 02:01 PM EDT
Updated: 02:25 PM

EMA committee recommends Alnylam’s early-stage ATTR amyloidosis drug for orphan status

by Amber Tongenvelope — on April 23, 2018 09:37 AM EDT

Pfizer hits stumbling block on Herceptin rival, but wins ‘breakthrough’ status on MenB vaccine

by Brittany Meilingenvelope — on April 23, 2018 09:21 AM EDT

Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage

by John Carrollenvelope — on April 23, 2018 08:00 AM EDT
Updated: 01:49 PM

After fruitless talks, a bid from Vas and plenty of patience, AveXis CEO Sean Nolan slowly reeled in an $8.7B deal

by John Carrollenvelope — on April 20, 2018 01:15 PM EDT

Novartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies

by John Carrollenvelope — on April 20, 2018 09:13 AM EDT

With Gilenya generics looming, Novartis’ siponimod team buffs up the MS data package being prepped for the FDA

by John Carrollenvelope — on April 20, 2018 09:07 AM EDT

Biogen pays $1B cash to enlist Ionis on a new drug discovery campaign — but can it deliver fast enough for analysts?

by John Carrollenvelope — on April 20, 2018 06:30 AM EDT
Updated: 06:48 AM

On second thought, Allergan doesn’t want to consider a bid for Shire, leaving Takeda in sole pursuit of $62.5B deal

by John Carrollenvelope — on April 19, 2018 03:43 PM EDT
Updated: 04:54 PM

GW Pharma walks away from adcomm with unanimous support for anti-seizure med. An OK shouldn’t take long now

by John Carrollenvelope — on April 19, 2018 01:21 PM EDT

  • 1
  • 2
  • 3
  • 133

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • Endpoints Careers
  • About Endpoints
  • Privacy Policy
  • Advertise/Media Kit

copyright 2018 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.